Liberty Mutual Group Asset Management Inc. Abb Vie Inc. Transaction History

Liberty Mutual Group Asset Management Inc.

  • $660 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019
SELL
$77.85 - $96.01 $4.72 Million - $5.82 Million
-60,577 Closed
0 $0
Q2 2018

Aug 10, 2018
SELL
$89.78 - $106.23 $265,479 - $314,122
-2,957 Reduced 4.65%
60,577 $5.61 Million
Q4 2017

Feb 12, 2018
SELL
$89.56 - $98.21 $946,649 - $1.04 Million
-10,570 Reduced 14.26%
63,534 $6.14 Million
Q3 2017

Nov 14, 2017
BUY
$69.85 - $89.22 $5.18 Million - $6.61 Million
74,104
74,104 $6.59 Million

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Liberty Mutual Group Asset Management Inc. Portfolio

Follow Liberty Mutual Group Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Liberty Mutual Group Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Liberty Mutual Group Asset Management Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email